Glaukos Corp
GKOSHealthcare·Medical Devices·USA·Large·NYSE·Nov 13 • 7:19 AM ET
247.20+1.17 (0.48%)
2026-11-13 13:31 CET
Market cap
$14.63B
Revenue, TTM
690.33 USD m
Net income, TTM
-169.80 USD m
Free cash flow, TTM
19.41 USD m
EPS diluted, TTM
-2.94
Price
GKOS against its 20, 50 and 200-day averagesPatternshover a marker to name it
3.1% under the 52-week high of 255.19 on 4 Nov 2026. 52-week low 87.32 on 18 Nov 2025. Last 15 sessions, 46.0% high to low
Volume 0.03× normal · the line is the 50-bar volume average
Setup. RS line 100
CANSLIM 6 of 6
VCP 4 of 6 — fails: Average True Range: Under 2; RSI (14): Not Overbought (<60)
Minervini 4 of 4
Zanger 4 of 5 — fails: Relative Volume: Over 1.5
Leaders 5 of 5
Breakout 2 of 4 — fails: 52-Week High/Low: New High; Relative Volume: Over 2
Growth 3 of 4 — fails: Return on Equity: Over +15%
Quality 1 of 5 — fails: Return on Equity: Over +15%; Net Profit Margin: High (>20%); Debt/Equity: Low (<0.1) — not on the tape: P/E: Under 25
Value 0 of 4 — fails: P/B: Under 2; Return on Equity: Over +15%; Debt/Equity: Low (<0.1) — not on the tape: P/E: Under 15
Income 0 of 4 — fails: Dividend Growth: Growing 2+ Years — not on the tape: Dividend Yield: Over 2%; Payout Ratio: Low (<20%); P/E: Under 25
Small Cap 4 of 4
Accumulation 3 of 4 — fails: Institutional Transactions: Over +10%
Relative Strength 3 of 3
Profile
GKOS52-week range, 95% of the way up
87.32255.19
Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology. The company was founded by Olav B. Bergheim, Morteza Gharib, and Richard A. Hill on July 14, 1998 and is headquartered in Aliso Viejo, CA.
| Index | RUT |
|---|---|
| Employees | 1094 |
| IPO | Jun 25, 2015 |
| Beta | 0.68 |
| ATR, 14d | 11.66 |
| Rel volume | 0.03 |
| Short float | 7.89% |
| Insider own | 3.97% |
| Inst own | 107.03% |
Snapshot
6 groupsValuation
| Index | RUT |
|---|---|
| Market Cap | $14.63B |
| Enterprise Value | 14.40B |
| Income | -169.80M |
| Sales | 690.33M |
| Book / share | 12.12 |
| Cash / share | 5.69 |
| Dividend Est. | - |
| Dividend TTM | - |
| Dividend Ex-Date | - |
| Dividend Gr. 3/5Y | - - |
| Payout | - |
| Employees | 1094 |
| IPO | Jun 25, 2015 |
Ratios
| Price / earnings | - |
|---|---|
| Forward price / earnings | 176.52 |
| Price / earnings / growth | - |
| Price / sales | 21.20 |
| Price / book | 20.39 |
| Price / cash | 43.46 |
| Price / free cash flow | 753.91 |
| Value / cash profit | - |
| Value / sales | 20.86 |
| Quick Ratio | 4.09 |
| Current Ratio | 4.57 |
| Debt / equity | 0.14 |
| Long-term debt / equity | 0.14 |
| Options and short | Yes / Yes |
Earnings
| Earnings / share | -2.94 |
|---|---|
| Earnings next year | 1.40 |
| Earnings next quarter | 0.50 |
| Earnings this year | 174.95% |
| Earnings next year | 107.60% |
| Earnings growth, 5 years | - |
| Past earnings growth | -16.22% -3.95% |
| Past sales growth | 21.51% 17.67% |
| Earnings vs last year | -89.79% |
| Sales vs last year | 46.94% |
| Earnings vs last quarter | 111.67% |
| Sales vs last quarter | 58.03% |
| Earnings | Oct 28 AMC |
| Surprise | 587.55% 25.58% |
Ownership
| Insiders own | 3.97% |
|---|---|
| Insider trades | -7.50% |
| Institutions own | 107.03% |
| Institution trades | 3.87% |
| Return on assets | -17.16% |
| Return on equity | -22.84% |
| Return on capital | -20.73% |
| Gross Margin | 81.13% |
| Operating margin | -8.95% |
| Profit Margin | -24.60% |
| 20-day average | 15.74% |
| 50-day average | 33.88% |
| 200-day average | 67.85% |
Technical
| Shares out | 59.17M |
|---|---|
| Shares floating | 56.85M |
| Short / float | 7.89% |
| Short ratio | 3.84 |
| Short interest | 4.48M |
| 52-week high | 255.19 -3.1% |
| 52-week low | 87.32 +183.1% |
| Volatility | 4.10% 5.41% |
| Average range | 11.66 |
| Strength index | 69.26 |
| Market sensitivity | 0.68 |
| Relative volume | 0.03 |
| Avg Volume | 1.17M |
| Volume | 1,698 |
Performance
| Perf Week | 10.16% |
|---|---|
| Perf Month | 49.28% |
| Perf Quarter | 33.18% |
| Perf Half Y | 71.65% |
| Perf YTD | 118.94% |
| Perf Year | 169.25% |
| Perf 3Y | 289.35% |
| Perf 5Y | 387.57% |
| Perf 10Y | 626.85% |
| Recommendation | 1.27 |
| Target Price | 242.46 |
| Prev Close | 246.03 |
| Price | 247.20 |
| Change % | 0.48% |
Analyst ratings
latest 10 of 20| Date | Action | Analyst | Rating change | Target | Implied |
|---|---|---|---|---|---|
| Jul 28, 2026 | Initiated | UBS | Neutral | ||
| Jul 06, 2026 | Initiated | H.C. Wainwright | Buy | $168 | -32.0% |
| Oct 27, 2025 | Upgrade | Wells Fargo | Equal Weight → Overweight | $120 | -51.5% |
| Oct 01, 2025 | Initiated | Goldman | Buy | $103 | -58.3% |
| May 01, 2025 | Downgrade | Wells Fargo | Overweight → Equal Weight | $86 | -65.2% |
| Feb 19, 2025 | Upgrade | Mizuho | Neutral → Outperform | $140 → $200 | -19.1% |
| Dec 11, 2024 | Upgrade | Citigroup | Neutral → Buy | $132 → $162 | -34.5% |
| Dec 06, 2024 | Initiated | UBS | Buy | $182 | -26.4% |
| Dec 02, 2024 | Downgrade | Morgan Stanley | Equal-Weight → Underweight | $120 | -51.5% |
| Jul 10, 2024 | Downgrade | Citigroup | Buy → Neutral | $132 | -46.6% |
Peers
Mkt capInsider trading
latest 14 of 89| Insider | Relationship | Date | Transaction | Cost | Shares | Value | Total held | Form |
|---|---|---|---|---|---|---|---|---|
| Gilliam Joseph E | Officer | Nov 12 '26 | Proposed Sale | 246.32 | 44,917 | 11,063,735 | Nov 12 04:23 PM | |
| Kliman Gilbert H | Director | Nov 04 '26 | Option Exercise | 25.77 | 2,500 | 64,425 | 39,906 | Nov 05 07:32 PM |
| Kliman Gilbert H | Director | Nov 04 '26 | Sale | 253.00 | 2,500 | 632,500 | 37,406 | Nov 05 07:32 PM |
| Kliman Gilbert H | Director | Nov 04 '26 | Proposed Sale | 253.00 | 2,500 | 632,500 | Nov 04 02:31 PM | |
| Navratil Tomas | CHIEF DEVELOPMENT OFFICER | Oct 30 '26 | Option Exercise | 75.97 | 12,969 | 985,196 | 81,764 | Nov 03 09:45 PM |
| Navratil Tomas | CHIEF DEVELOPMENT OFFICER | Oct 30 '26 | Sale | 238.97 | 44,436 | 10,618,980 | 37,328 | Nov 03 09:45 PM |
| Navratil Tomas | Officer | Oct 30 '26 | Proposed Sale | 238.97 | 44,436 | 10,618,942 | Oct 30 01:04 PM | |
| Navratil Tomas | CHIEF DEVELOPMENT OFFICER | Oct 05 '26 | Sale | 164.45 | 1,527 | 251,120 | 69,291 | Oct 07 07:07 PM |
| Navratil Tomas | Officer | Oct 05 '26 | Proposed Sale | 164.45 | 1,527 | 251,121 | Oct 05 04:08 PM | |
| Navratil Tomas | CHIEF DEVELOPMENT OFFICER | Sep 25 '26 | Sale | 154.28 | 1,615 | 249,158 | 70,818 | Sep 28 06:23 PM |
| Navratil Tomas | Officer | Sep 25 '26 | Proposed Sale | 154.28 | 1,615 | 249,158 | Sep 25 04:10 PM | |
| Navratil Tomas | CHIEF DEVELOPMENT OFFICER | Sep 16 '26 | Sale | 166.92 | 1,457 | 243,204 | 72,433 | Sep 18 05:32 PM |
| Navratil Tomas | Officer | Sep 16 '26 | Proposed Sale | 166.92 | 1,457 | 243,207 | Sep 16 04:17 PM | |
| Navratil Tomas | CHIEF DEVELOPMENT OFFICER | Aug 28 '26 | Sale | 180.67 | 13,744 | 2,483,104 | 73,890 | Sep 01 06:24 PM |
Held by
AUM| Ticker | Company | AUM |
|---|---|---|
| IJH | iShares Core S&P Mid-Cap ETF | AUM: 125.56B |
| IWM | iShares Russell 2000 Index Fund | AUM: 77.86B |
| VTI | Vanguard Morningstar Total Stock Market ETF | AUM: 696.31B |
| VB | Vanguard Morningstar Small-Cap ETF | AUM: 80.23B |
| IWO | iShares Russell 2000 Growth ETF | AUM: 14.25B |
| VBK | Vanguard Morningstar Small-Cap Growth ETF | AUM: 22.68B |
| VXF | Vanguard Extended Market Index ETF | AUM: 30.79B |
| MDY | State Street SPDR S&P MIDCAP 400 ETF Trust | AUM: 26.08B |
| BLCR | iShares Large Cap Core Active ETF | AUM: 9.91B |
| SPMD | State Street SPDR Portfolio S&P 400TM Mid Cap ETF | AUM: 19.06B |
News
latest 14 of 200- Glaukos Announces Participation in Upcoming Investor Conferences (Business Wire)
- Okta Is Joining the S&P 500 as Kenvue Leaves (Barrons.com)
- Okta Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 (PR Newswire)
- Why Glaukos Stock Is Surging 30% and Headed for Record Close After Earnings (Barrons.com) +33.65%
- Glaukos Swings To A Profit As Epioxa Ramps And A $1 Billion 2027 Outlook Raises The Stakes On IDose Coverage Risk (Earnings Whispers)
- Glaukos: Q3 Earnings Snapshot (Associated Press)
- Glaukos Announces Third Quarter 2026 Financial Results (Business Wire)
- Glaukos Faces Seasonal Test As Epioxa's J-Code Reset Meets A Raised Outlook (Earnings Whispers)
- Glaukos Announces Positive Topline Results from Phase 4 Prospective Randomized Controlled Clinical Trial Evaluating iDose TR in Combination with Cataract Surgery (Business Wire)
- Glaukos Announces Exclusive License Agreement with RevOpsis Therapeutics to Develop and Commercialize RO-104, a First-in-Class Tri-Specific Biologic for Retinal Diseases (Business Wire) -6.32%
- Glaukos Announces Positive Three-Year Epioxa Results Demonstrating Durable Clinical Outcomes in Keratoconus (Business Wire) +6.55%
- Glaukos to Release Third Quarter 2026 Financial Results after Market Close on October 28 (Business Wire)
- Glaukos Partners with NBA Champion Stephen Curry to Launch "Could it be KC?" Campaign to Raise Awareness of Keratoconus (Business Wire)
- Glaukos Announces Participation in Wells Fargo Healthcare Conference (Business Wire)
Quarterly earnings
2026Q3 EPS 0.470 beat -0.096, from -0.160 a year earlier. Sales 211.03 beat 168.04, from 133.54 a year earlier
The outline behind the bar is the estimate. The filled bar is the print. Green beat it, red missed it.
| Period | Reported | EPS adjusted | EPS est | EPS reported | Sales act, USD m | Sales est, USD m | Surprise | Year-ago quarter | Analysts | Next session |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026Q3ended 2026-09-30 | 2026-10-28 16:30 | 0.470 | -0.096 | 0.030 | 211.03 | 168.04 | EPS -587.6% · sales +25.6% | vs 2025Q3, year-ago quarter · EPS -393.7% · sales +58.0% | 12 EPS · 14 sales | Open +16.30% vs SPY -0.46%. Close +33.65% vs SPY -0.38% |
| 2026Q2ended 2026-06-30 | 2026-07-29 16:30 | -0.140 | -0.211 | -0.312 | 185.61 | 150.93 | EPS -33.5% · sales +23.0% | vs 2025Q2, year-ago quarter · EPS -41.7% · sales +49.5% | 13 EPS · 14 sales | Open +11.48% vs SPY +0.90%. Close +4.24% vs SPY +1.68% |
| 2026Q1ended 2026-03-31 | 2026-04-29 16:30 | -0.180 | -0.281 | -0.341 | 150.57 | 137 | EPS -35.9% · sales +9.9% | vs 2025Q1, year-ago quarter · EPS -18.2% · sales +41.2% | 13 | Open +20.98% vs SPY +0.43%. Close +22.84% vs SPY +0.99% |
| 2025Q4ended 2025-12-31 | 2026-02-17 16:30 | -0.280 | -0.196 | -2.324 | 143.12 | 136.4 | EPS +43.1% · sales +4.9% | vs 2024Q4, year-ago quarter · EPS -30.0% · sales +35.7% | 15 EPS · 14 sales | Open -2.90% vs SPY +0.17%. Close +13.47% vs SPY +0.50% |
| 2025Q3ended 2025-09-30 | 2025-10-29 16:30 | -0.160 | -0.261 | -0.283 | 133.54 | 122.44 | EPS -38.6% · sales +9.1% | vs 2024Q3, year-ago quarter · EPS -42.9% · sales +38.1% | 15 EPS · 14 sales | Open +23.32% vs SPY -0.51%. Close +13.89% vs SPY -1.10% |
| 2025Q2ended 2025-06-30 | 2025-07-30 16:30 | -0.240 | -0.264 | -0.344 | 124.12 | 115.52 | EPS -9.2% · sales +7.4% | vs 2024Q2, year-ago quarter · EPS -53.8% · sales +29.7% | 15 EPS · 14 sales | Open -0.58% vs SPY +0.79%. Close -8.46% vs SPY -0.38% |
| 2025Q1ended 2025-03-31 | 2025-04-30 16:30 | -0.220 | -0.348 | -0.320 | 106.66 | 102.48 | EPS -36.8% · sales +4.1% | vs 2024Q1, year-ago quarter · EPS -68.6% · sales +24.6% | 15 EPS · 14 sales | Open -10.43% vs SPY +1.05%. Close -11.36% vs SPY +0.71% |
| 2024Q4ended 2024-12-31 | 2025-02-20 16:30 | -0.400 | -0.383 | -0.604 | 105.5 | 100.75 | EPS +4.3% · sales +4.7% | vs 2023Q4, year-ago quarter · EPS -36.5% · sales +28.1% | 15 EPS · 14 sales | Open -10.17% vs SPY -0.04%. Close -20.01% vs SPY -1.71% |
| 2024Q3ended 2024-09-30 | 2024-11-04 16:30 | -0.280 | -0.478 | -0.389 | 96.67 | 91.50 | EPS -41.4% · sales +5.7% | vs 2023Q3, year-ago quarter · EPS -44.0% · sales +23.9% | 12 EPS · 11 sales | Open -4.86% vs SPY +0.16%. Close -2.68% vs SPY +1.21% |
| 2024Q2ended 2024-06-30 | 2024-07-31 16:30 | -0.520 | -0.515 | -0.997 | 95.69 | 88.86 | EPS +0.9% · sales +7.7% | vs 2023Q2, year-ago quarter · EPS -5.5% · sales +19.0% | 13 EPS · 12 sales | Open -5.23% vs SPY +0.32%. Close +0.38% vs SPY -1.42% |
| 2024Q1ended 2024-03-31 | 2024-05-01 16:30 | -0.700 | -0.577 | -0.824 | 85.62 | 79.60 | EPS +21.3% · sales +7.6% | vs 2023Q1, year-ago quarter · EPS +18.6% · sales +15.9% | 12 | Open -2.04% vs SPY +0.76%. Close +6.19% vs SPY +0.94% |
| 2023Q4ended 2023-12-31 | 2024-02-21 16:30 | -0.630 | -0.549 | -0.753 | 82.37 | 81.00 | EPS +14.7% · sales +1.7% | vs 2022Q4, year-ago quarter · EPS +18.9% · sales +15.6% | 13 EPS · 1 sales | Open +3.01% vs SPY +1.37%. Close -1.43% vs SPY +2.07% |
| 2023Q3ended 2023-09-30 | 2023-11-01 16:30 | -0.500 | -0.550 | -0.625 | 78.05 | 75.25 | EPS -9.1% · sales +3.7% | vs 2022Q3, year-ago quarter · EPS +11.1% · sales +9.5% | 12 EPS · 11 sales | - |
| 2023Q2ended 2023-06-30 | 2023-08-02 16:30 | -0.550 | -0.555 | -0.680 | 80.40 | 74.73 | EPS -1.0% · sales +7.6% | vs 2022Q2, year-ago quarter · EPS -33.7% · sales +10.6% | 12 EPS · 11 sales | - |
| 2023Q1ended 2023-03-31 | 2023-05-03 16:30 | -0.590 | -0.575 | -0.723 | 73.90 | 67.59 | EPS +2.6% · sales +9.3% | vs 2022Q1, year-ago quarter · EPS +55.3% · sales +9.2% | 12 EPS · 11 sales | - |
| 2022Q4ended 2022-12-31 | 2023-02-22 16:30 | -0.530 | -0.546 | -0.659 | 71.23 | 68.07 | EPS -2.9% · sales +4.6% | vs 2021Q4, year-ago quarter · EPS +71.0% · sales -2.7% | 12 EPS · 11 sales | - |
Annual earnings
2025FY EPS -0.900 missed -0.823, from -1.860 a year earlier. Sales 507.44 beat 500.21, from 383.48 a year earlier
Reported years only. The outline behind the bar is the estimate. A later year with no print stays in the table.
earnings feed, not the snapshot. Not the statement ratio.
| Period | EPS adjusted | EPS est | EPS reported | Sales act, USD m | Sales est, USD m | P/E, earnings feed |
|---|---|---|---|---|---|---|
| 2030FYestimate | - | 5.350 | - | - | 1,818 | 46.21 |
| 2029FYestimate | - | 3.960 | - | - | 1,604 | 62.42 |
| 2028FYestimate | - | 2.408 | - | - | 1,295 | 102.67 |
| 2027FYestimate | - | 1.400 | - | - | 1,003 | 176.52 |
| 2026FYestimate | - | 0.675 | - | - | 780.53 | 366.49 |
| 2025FY | -0.900 | -0.823 | -3.280 | 507.44 | 500.21 | - |
| 2024FY | -1.860 | -1.830 | -2.775 | 383.48 | 378.74 | - |
| 2023FY | -2.270 | -2.220 | -2.780 | 314.71 | 313 | - |
| 2022FY | -2.180 | -2.200 | -2.091 | 282.86 | 279.63 | - |
| 2021FY | -0.830 | -0.879 | -1.068 | 294.01 | 288.16 | - |
| 2020FY | -1.150 | -1.499 | -2.705 | 224.96 | 220 | - |
| 2019FY | -0.100 | -0.724 | 0.375 | 236.98 | 234.05 | - |
| 2018FY | -0.370 | -0.553 | -0.367 | 181.28 | 176.94 | - |
| 2017FY | 0.140 | 0.060 | -0.003 | 159.25 | 158.48 | 183.21 |
| 2016FY | 0.120 | 0.123 | 0.120 | 114.4 | 111.11 | 285.83 |
| 2015FY | -2.130 | -1.482 | -2.130 | 71.70 | 71.60 | - |
| 2014FY | -0.536 | - | -0.549 | 45.80 | - | - |
Quarterly results
2026Q3 revenue 211.03, from 133.54 a year earlier. Operating margin 0.4%, from -12.3% a year earlier
From the quarterly statement. Not an estimate.
Estimate revisions
Latest snapshot of each period and type. 2026FY E 0.67 per share.
| Period | Type | Scale | Date | Mean | vs prior date |
|---|---|---|---|---|---|
| 2026FY | E | per share | 2026-10-29 | 0.67 | -321.6% |
| 2026Q4 | E | per share | 2026-10-29 | 0.50 | +288.4% |
| 2026FY | R | per share | 2026-10-29 | 0.05 | -106.3% |
| 2026Q4 | R | per share | 2026-10-29 | 0.41 | +3310.9% |
| 2026FY | S | - | 2026-10-29 | 780.53 | +12.8% |
| 2026Q4 | S | - | 2026-10-29 | 233.33 | +24.5% |
| 2026Q3 | E | per share | 2026-10-27 | -0.10 | 0.0% |
| 2026Q3 | S | - | 2026-10-27 | 168.04 | 0.0% |
| 2026Q3 | R | per share | 2026-10-16 | -0.22 | +6.1% |
| 2026Q2 | E | per share | 2026-07-27 | -0.21 | -5.7% |
| 2026Q2 | R | per share | 2026-07-27 | -0.27 | -7.3% |
| 2026Q2 | S | - | 2026-07-27 | 150.93 | 0.0% |
| 2026Q1 | E | per share | 2026-04-21 | -0.28 | +0.3% |
| 2026Q1 | R | per share | 2026-04-21 | -0.37 | +0.3% |
| 2026Q1 | S | - | 2026-04-21 | 137 | 0.0% |
| 2025Q4 | E | per share | 2026-02-13 | -0.20 | +0.1% |
| 2025FY | S | - | 2026-02-13 | 500.21 | +0.0% |
| 2025Q4 | S | - | 2026-02-13 | 136.4 | 0.0% |
| 2025FY | E | per share | 2026-01-29 | -0.82 | -1.5% |
| 2025FY | R | per share | 2026-01-26 | -1.17 | -0.9% |
| 2025Q4 | R | per share | 2026-01-26 | -0.29 | -3.4% |
| 2025Q3 | E | per share | 2025-10-19 | -0.26 | 0.0% |
| 2025Q3 | R | per share | 2025-10-18 | -0.32 | 0.0% |
| 2025Q3 | S | - | 2025-10-18 | 122.44 | 0.0% |
| 2025Q2 | E | per share | 2025-07-27 | -0.26 | 0.0% |
| 2025Q2 | S | - | 2025-07-21 | 115.52 | 0.0% |
| 2025Q2 | R | per share | 2025-07-15 | -0.33 | 0.0% |
| 2025Q1 | E | per share | 2025-04-25 | -0.35 | 0.0% |
| 2025Q1 | S | - | 2025-04-25 | 102.48 | +0.0% |
| 2025Q1 | R | per share | 2025-03-25 | -0.40 | -0.8% |
| 2024FY | E | per share | 2025-02-18 | -1.83 | +0.5% |
| 2024Q4 | E | per share | 2025-02-18 | -0.38 | +2.1% |
| 2024FY | R | per share | 2025-02-18 | -2.48 | +0.5% |
| 2024Q4 | R | per share | 2025-02-18 | -0.45 | +2.7% |
| 2024FY | S | - | 2025-02-18 | 378.74 | +0.1% |
| 2024Q4 | S | - | 2025-02-18 | 100.75 | +0.2% |
| 2024Q3 | E | per share | 2024-10-28 | -0.48 | 0.0% |
| 2024Q3 | S | per share | 2024-10-28 | 91.50 | 0.0% |
| 2024Q3 | R | per share | 2024-10-15 | -0.58 | 0.0% |
| 2024Q2 | E | per share | 2024-07-25 | -0.52 | 0.0% |
| 2024Q2 | R | per share | 2024-07-16 | -0.59 | 0.0% |
| 2024Q2 | S | per share | 2024-07-16 | 88.86 | 0.0% |
| 2024Q1 | E | per share | 2024-04-30 | -0.58 | +0.6% |
| 2024Q1 | R | per share | 2024-04-26 | -0.65 | -1.0% |
| 2024Q1 | S | per share | 2024-04-12 | 79.60 | 0.0% |
| 2023FY | E | per share | 2024-02-16 | -2.22 | +0.1% |
| 2023FY | R | per share | 2024-02-16 | -2.50 | +0.1% |
| 2023FY | S | - | 2024-01-09 | 313 | +1.3% |
Estimate history
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | MRQ |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS per share | -0.003 | -0.367 | 0.375 | -2.705 | -1.068 | -2.091 | -2.78 | -2.775 | -3.282 | -2.9447 | - |
| Sales USD millions | 159 | 181 | 237 | 225 | 294 | 283 | 315 | 383 | 507 | 690 | - |
| Shares million shares | 35 | 36 | 44 | 45 | 47 | 48 | 49 | 56 | 58 | - | 59 |
| Metric | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|---|
| EPS per share | -0.389 | -0.604 | -0.32 | -0.344 | -0.283 | -2.324 | -0.341 | -0.312 | 0.033 |
| Sales USD millions | 97 | 105 | 107 | 124 | 134 | 143 | 151 | 186 | 211 |
| Shares million shares | 55 | 56 | 57 | 57 | 57 | 58 | 58 | 59 | 59 |
Income statement, annual
| Metric | TTM | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 | 2022FY12/31/2022 | 2021FY12/31/2021 | 2020FY12/31/2020 | 2019FY12/31/2019 | 2018FY12/31/2018 |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 690.33 | 507.44+32.3% | 383.48+21.9% | 314.71+11.3% | 282.86-3.8% | 294.01+30.7% | 224.96-5.1% | 236.98+30.7% | 181.28 |
| Cost of Goods Sold Incl. D&A | 130.29 | 114.23+18.5% | 96.41+23.6% | 78.00+9.2% | 71.40+3.4% | 69.05-26.7% | 94.14+133.0% | 40.41+61.2% | 25.07 |
| Gross Profit | 560.04 | 393.22+37.0% | 287.07+21.3% | 236.72+11.9% | 211.46-6.0% | 224.96+72.0% | 130.82-33.4% | 196.57+25.8% | 156.20 |
| Selling, General and Administrative Excl. Other | 621.84 | 479.95+21.4% | 395.21+9.7% | 360.42+14.9% | 313.77+12.9% | 277.83+9.2% | 254.37+14.7% | 221.82+31.1% | 169.21 |
| Research and Development | 187.19 | 150.61+10.4% | 136.43-1.7% | 138.77+12.6% | 123.27+22.0% | 101.00+18.3% | 85.39+25.0% | 68.31+37.5% | 49.68 |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -61.80 | -86.73 | -108.14 | -123.70 | -102.31 | -52.87 | -123.55 | -25.25 | -13.00 |
| Interest Expense | 4.82 | 4.63-83.5% | 28.05+105.8% | 13.63-0.7% | 13.72+2.6% | 13.37-5.3% | 14.12+451.6% | 2.56 | 0.00 |
| Unusual Expense | 114.37 | 112.87+693.2% | 14.23+184.6% | 5.00 | -20.00 | -20.00 | 0.00-100.0% | 25.05 | 0.00 |
| Net Income Before Taxes | -174.51 | -193.04 | -145.60 | -133.73 | -98.43 | -49.27 | -132.31 | -50.04 | -12.37 |
| Income Taxes | -4.72 | -5.35-794.8% | 0.77-17.2% | 0.93+20.8% | 0.77+133.3% | 0.33 | -11.97 | -65.46-11386.2% | 0.58 |
| Consolidated Net Income | -169.80 | -187.69 | -146.37 | -134.66 | -99.19 | -49.59 | -120.35-880.5% | 15.42 | -12.95 |
| Net Income From Continuing Operations | -169.80 | -187.69 | -146.37 | -134.66 | -99.19 | -49.59 | -120.35-880.5% | 15.42 | -12.95 |
| Net Income | -169.80 | -187.69 | -146.37 | -134.66 | -99.19 | -49.59 | -120.35-880.5% | 15.42 | -12.95 |
| EPS (Recurring) per share | -1.47 | -1.90 | -2.59 | -2.71 | -2.39 | -1.37 | -2.70-437.5% | 0.80 | -0.37 |
| EPS (Basic, Before Extraordinaries) per share | -2.94 | -3.28 | -2.77 | -2.78 | -2.09 | -1.07 | -2.70-758.5% | 0.41 | -0.37 |
| EPS (Diluted) per share | -2.94 | -3.28 | -2.77 | -2.78 | -2.09 | -1.07 | -2.70-829.7% | 0.37 | -0.37 |
| EBITDA | -15.51 | -44.39 | -68.22 | -85.72 | -66.37 | -18.45 | -88.94 | -15.38 | -6.74 |
| Non-Operating Income (Expense) | 6.46 | 11.19+132.2% | 4.82-44.0% | 8.61 | -2.40 | -3.02-156.4% | 5.35+89.7% | 2.82+347.6% | 0.63 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 70.31 | 54.62+80.8% | 30.21-21.0% | 38.23-2.1% | 39.06+118.8% | 17.85-55.2% | 39.80+14.1% | 34.88+129.5% | 15.20 |
| Price To Earnings Ratio ratio statement ratio, not the snapshot | - | - | - | - | - | - | - | 204.16 | - |
| Price To Sales Ratio ratio | 14.55 | 12.73 | 20.63 | 12.23 | 7.33 | 7.02 | 14.89 | 9.46 | 10.94 |
| Gross Margin % | 81.13 | 77.49 | 74.86 | 75.22 | 74.76 | 76.52 | 58.15 | 82.95 | 86.17 |
| Operating Margin % | -8.95 | -17.09 | -28.20 | -39.31 | -36.17 | -17.98 | -54.92 | -10.65 | -7.17 |
| Net Margin % | -24.60 | -36.99 | -38.17 | -42.79 | -35.07 | -16.87 | -53.50 | 6.51 | -7.14 |
| Shares Outstanding million shares | 59.17 | 57.51+1.9% | 56.44+14.9% | 49.12+2.9% | 47.75+1.7% | 46.97+3.8% | 45.25+4.0% | 43.50+20.5% | 36.11 |
| Market Capitalization | 14,564.21 | 14,564.21+76.2% | 8,267.30+113.1% | 3,879.08+86.2% | 2,083.680.0% | 2,083.80-38.4% | 3,383.80+43.4% | 2,359.81+16.6% | 2,023.69 |
Income statement, quarterly
| Metric | 2026Q39/30/2026 | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q412/31/2024 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 211.03+58.0% | 185.61+49.5% | 150.57+41.2% | 143.12+35.7% | 133.54+38.1% | 124.12+29.7% | 106.66+24.6% | 105.50+28.1% |
| Cost of Goods Sold Incl. D&A | 31.16+8.1% | 34.02+26.5% | 33.34+37.1% | 31.77+10.9% | 28.83+27.7% | 26.90+19.3% | 24.32+20.0% | 28.64+113.9% |
| Gross Profit | 179.87+71.8% | 151.59+55.9% | 117.23+42.4% | 111.35+44.9% | 104.71+41.3% | 97.22+32.9% | 82.35+26.0% | 76.86+11.4% |
| Selling, General and Administrative Excl. Other | 179.04+47.9% | 167.36+39.6% | 137.09+33.1% | 138.35+31.1% | 121.07+22.6% | 119.91+19.2% | 103.03+11.1% | 105.53+6.2% |
| Research and Development | 48.09+26.3% | 51.30+40.4% | 44.15+36.5% | 43.65+19.5% | 38.07+9.6% | 36.54+6.1% | 32.35+5.3% | 36.53-1.4% |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | 0.83 | -15.77 | -19.86 | -27.00 | -16.36 | -22.69 | -20.68 | -28.67 |
| Interest Expense | 1.09-7.6% | 1.46+27.0% | 1.12-3.4% | 1.15-26.8% | 1.18-28.9% | 1.15-94.6% | 1.16-66.4% | 1.57-54.2% |
| Unusual Expense | 0.00 | 1.50 | 0.00 | 112.87 | 0.00 | 0.00-100.0% | 0.00-100.0% | 0.00-100.0% |
| Net Income Before Taxes | 2.32 | -17.72 | -19.30 | -139.82 | -16.00 | -19.41 | -17.82 | -33.69 |
| Income Taxes | 0.30+30.4% | 0.66+164.0% | 0.48+45.5% | -6.16 | 0.23+27.8% | 0.25-24.2% | 0.33-13.2% | -0.11-283.3% |
| Consolidated Net Income | 2.02 | -18.38 | -19.78 | -133.66 | -16.23 | -19.66 | -18.15 | -33.58 |
| Net Income From Continuing Operations | 2.02 | -18.38 | -19.78 | -133.66 | -16.23 | -19.66 | -18.15 | -33.58 |
| Net Income | 2.02 | -18.38 | -19.78 | -133.66 | -16.23 | -19.66 | -18.15 | -33.58 |
| EPS (Recurring) per share | 0.03 | -0.29 | -0.34 | -0.95 | -0.28 | -0.34 | -0.32 | -0.60 |
| EPS (Basic, Before Extraordinaries) per share | 0.03 | -0.31 | -0.34 | -2.32 | -0.28 | -0.34 | -0.32 | -0.60 |
| EPS (Diluted) per share | 0.03 | -0.31 | -0.34 | -2.32 | -0.28 | -0.34 | -0.32 | -0.60 |
| EBITDA | 10.86 | -5.62 | -6.97 | -13.77 | -6.18 | -13.06 | -11.37 | -15.65 |
| Non-Operating Income (Expense) | 2.58+67.5% | 1.00-77.4% | 1.68-58.2% | 1.20 | 1.54-69.7% | 4.43+292.0% | 4.02+95.1% | -3.46-164.9% |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 14.04+19.2% | 22.80+60.1% | 15.12+47.4% | 18.34+74.5% | 11.78+3.4% | 14.24+59.3% | 10.26+16.3% | 10.51-25.5% |
| Price To Sales Ratio ratio | 14.55 | 13.41 | 11.33 | 12.80 | 9.96 | 13.65 | 13.78 | 21.73 |
| Gross Margin % | 85.23 | 81.67 | 77.86 | 77.80 | 78.41 | 78.33 | 77.20 | 72.86 |
| Operating Margin % | 0.39 | -8.49 | -13.19 | -18.87 | -12.26 | -18.28 | -19.39 | -27.17 |
| Net Margin % | 0.96 | -9.90 | -13.14 | -93.39 | -12.15 | -15.84 | -17.01 | -31.83 |
| Shares Outstanding million shares | 59.17+3.1% | 58.86+2.8% | 58.36+2.9% | 57.51+1.9% | 57.39+4.2% | 57.25+4.4% | 56.74+13.8% | 56.44+14.9% |
| Market Capitalization | 14,564.21+211.4% | 8,208.65+39.1% | 6,252.76+12.3% | 6,484.95-21.6% | 4,676.89-34.7% | 5,902.04-1.0% | 5,567.36+19.4% | 8,267.30+113.1% |
Balance sheet, annual
| Metric | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 | 2022FY12/31/2022 | 2021FY12/31/2021 | 2020FY12/31/2020 | 2019FY12/31/2019 | 2018FY12/31/2018 | 2017FY12/31/2017 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 278.76-12.6% | 318.92+8.0% | 295.43-16.2% | 352.69-14.8% | 414.05+2.4% | 404.37+132.4% | 173.98+23.8% | 140.49+18.0% | 119.01 |
| Short Term Receivables | 108.61+78.8% | 60.74+52.4% | 39.85+10.5% | 36.07+7.9% | 33.44-7.3% | 36.06-6.1% | 38.42+105.8% | 18.67+12.1% | 16.66 |
| Inventories | 63.56+10.2% | 57.68+37.4% | 41.99+11.0% | 37.84+64.5% | 23.01+45.5% | 15.81-62.9% | 42.58+220.6% | 13.28+18.4% | 11.22 |
| Other Current Assets | 24.05+93.0% | 12.46-31.5% | 18.19+5.4% | 17.25+10.4% | 15.63+18.3% | 13.21+67.2% | 7.90+91.7% | 4.12+60.3% | 2.57 |
| Total Current Assets | 474.98+5.6% | 449.79+13.7% | 395.46-10.9% | 443.86-8.7% | 486.13+3.6% | 469.44+78.6% | 262.88+48.9% | 176.57+18.1% | 149.46 |
| Net Property, Plant & Equipment | 184.18+8.4% | 169.94-2.6% | 174.54+4.6% | 166.83+14.2% | 146.13+53.1% | 95.46+4.0% | 91.81+379.4% | 19.15+62.4% | 11.79 |
| Total Investments and Advances | 23.38+20.1% | 19.47+232.3% | 5.86-17.2% | 7.08-24.8% | 9.42-1.6% | 9.57+2.6% | 9.33+6.3% | 8.78 | 0.00 |
| Intangible Assets | 208.63-36.7% | 329.58-5.6% | 349.09-6.7% | 374.00-6.2% | 398.92-5.9% | 423.83-5.6% | 448.74 | 0.00-100.0% | 3.15 |
| Deferred Tax Assets | 36.89-39.9% | 61.39-7.7% | 66.52-7.3% | 71.78-9.3% | 79.13 | - | 0.00-100.0% | 0.21-8.7% | 0.23 |
| Other Assets | 2.32-61.1% | 5.97-61.4% | 15.47+45.8% | 10.61+16.5% | 9.11+26.4% | 7.21+27.6% | 5.65+150.0% | 2.26+88.3% | 1.20 |
| Total Assets | 930.37-10.2% | 1,036.15+2.9% | 1,006.94-6.3% | 1,074.17-4.8% | 1,128.83+12.3% | 1,005.50+22.9% | 818.40+295.4% | 206.97+24.8% | 165.84 |
| Short Term Debt Incl. Current Port. of LT Debt | 2.67+8.1% | 2.47+88.5% | 1.31+204.7% | 0.43-57.4% | 1.01-15.1% | 1.19-50.4% | 2.40 | 0.00 | 0.00 |
| Accounts Payable | 24.62+88.9% | 13.03-3.1% | 13.44-6.7% | 14.40+96.5% | 7.33+67.7% | 4.37-24.4% | 5.78-8.1% | 6.29+0.8% | 6.24 |
| Other Current Liabilities | 73.98+24.1% | 59.62+0.6% | 59.27+3.0% | 57.53+4.6% | 55.02+24.6% | 44.15-10.8% | 49.52+105.6% | 24.08+17.2% | 20.54 |
| Total Current Liabilities | 101.28+34.8% | 75.12+1.5% | 74.01+2.3% | 72.36+14.2% | 63.36+27.5% | 49.70-13.9% | 57.70+90.1% | 30.36+13.3% | 26.79 |
| Long Term Debt | 103.88+0.5% | 103.40-73.1% | 383.74+0.3% | 382.48+0.0% | 382.38+41.2% | 270.81+272.9% | 72.63 | 0.00 | 0.00 |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Liabilities | 37.33-45.4% | 68.32-7.3% | 73.67-6.8% | 79.05-8.6% | 86.45+722.5% | 10.51+9.1% | 9.63 | - | - |
| Other Liabilities | 31.74+41.9% | 22.37+62.7% | 13.75+33.8% | 10.28+8.3% | 9.49+35.0% | 7.03+36.0% | 5.17+88.0% | 2.75+223.5% | 0.85 |
| Total Liabilities | 274.22+1.9% | 269.22-50.6% | 545.17+0.2% | 544.16+0.5% | 541.68+60.2% | 338.05+132.9% | 145.13+338.3% | 33.11+19.8% | 27.63 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 656.15-14.4% | 766.93+66.1% | 461.77-12.9% | 530.00-9.7% | 587.15-12.0% | 667.45-0.9% | 673.27+287.2% | 173.86+25.8% | 138.20 |
| Total Shareholders Equity | 656.15-14.4% | 766.93+66.1% | 461.77-12.9% | 530.00-9.7% | 587.15-12.0% | 667.45-0.9% | 673.27+287.2% | 173.86+25.8% | 138.20 |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | 656.15-14.4% | 766.93+66.1% | 461.77-12.9% | 530.00-9.7% | 587.15-12.0% | 667.45-0.9% | 673.27+287.2% | 173.86+25.8% | 138.20 |
| Total Liabilities & Stockholders Equity | 930.37-10.2% | 1,036.15+2.9% | 1,006.94-6.3% | 1,074.17-4.8% | 1,128.83+12.3% | 1,005.50+22.9% | 818.40+295.4% | 206.97+24.8% | 165.84 |
| Book Value Per Share per share | 11.41-16.0% | 13.59+44.6% | 9.40-15.3% | 11.10-11.2% | 12.50-15.3% | 14.75-4.7% | 15.48+221.2% | 4.82+20.8% | 3.99 |
| Tangible Book Value Per Share per share | 7.78+0.4% | 7.75+238.4% | 2.29-30.0% | 3.27-18.5% | 4.01-25.5% | 5.38+4.3% | 5.16+7.1% | 4.82+23.6% | 3.90 |
| Full-Time Employees people | 1,094+9.9% | 995+9.7% | 907+15.8% | 783+7.7% | 727+11.3% | 653+8.8% | 600+37.3% | 437+12.9% | 387 |
| Price to Book Ratio ratio | 20.30 | 12.36 | 8.11 | 3.80 | 3.55 | 5.10 | 3.52 | 11.67 | 6.71 |
| Return on Assets % | -19.09 | -14.33 | -12.94 | -9.01 | -4.65 | -13.20 | 3.01 | -6.95 | -0.06 |
| Return on Equity % | -26.38 | -23.83 | -27.16 | -17.76 | -7.91 | -17.95 | 3.64 | -8.30 | -0.07 |
| Return on Invested Capital % | -24.70 | -16.82 | -15.93 | -10.87 | -5.12 | -12.83 | 2.07 | -7.45 | -0.07 |
| Quick Ratio ratio | 4.06 | 5.22 | 4.78 | 5.61 | 7.31 | 9.13 | 3.82 | 5.38 | 5.16 |
| Current Ratio ratio | 4.69 | 5.99 | 5.34 | 6.13 | 7.67 | 9.45 | 4.56 | 5.81 | 5.58 |
Cash flow, annual
| Metric | TTM | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 | 2022FY12/31/2022 | 2021FY12/31/2021 | 2020FY12/31/2020 | 2019FY12/31/2019 | 2018FY12/31/2018 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | -169.80 | -187.69 | -146.37 | -134.66 | -99.19 | -49.59 | -120.35-880.5% | 15.42 | -12.95 |
| Depreciation | 46.28 | 42.34+6.1% | 39.92+5.1% | 37.98+5.6% | 35.95+4.4% | 34.42-0.5% | 34.61+251.0% | 9.86+57.5% | 6.26 |
| Other Funds (Non Cash) | 222.05 | 185.06+118.2% | 84.82+72.5% | 49.18+12.6% | 43.67+17.0% | 37.33-52.2% | 78.15+73.2% | 45.12+54.9% | 29.13 |
| Funds from Operations | 92.05 | 33.23 | -21.84 | -47.62 | -19.64-192.9% | 21.13 | -19.76-582.0% | 4.10-81.7% | 22.44 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | -44.34 | -48.02 | -39.47 | -10.13 | -13.45-475.7% | 3.58 | -3.22 | -4.47 | -3.58 |
| Cash from Operating Activities | 47.71 | -14.79 | -61.32 | -57.76 | -33.08-233.9% | 24.71 | -22.99 | -0.37-102.0% | 18.86 |
| Capital Expenditures | -28.30 | -24.27 | -6.30 | -20.25 | -30.27 | -47.78 | -6.93 | -4.72 | -10.31 |
| Net Assets From Acquisitions | 0.00 | -12.44 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - |
| Sale of Fixed Assets and Businesses | - | 0.00-100.0% | 0.04 | 0.00-100.0% | 0.15 | 0.00 | 0.00-100.0% | 49.65 | - |
| Purchase or Sale of Investments | 0.74 | -35.35-161.8% | 57.24+52.6% | 37.51-50.6% | 75.90 | -8.37 | -196.31-178563.6% | 0.11 | -14.85 |
| Purchase of Investments | -159.56 | -232.29 | -189.96 | -265.59 | -59.26 | -215.28 | -301.00 | -80.39 | -93.70 |
| Sale Or Maturity of Investments | 160.30 | 196.94-20.3% | 247.20-18.4% | 303.10+124.3% | 135.16-34.7% | 206.92+97.6% | 104.70+30.1% | 80.49+2.1% | 78.85 |
| Other Uses | 11.32 | -5.55 | -3.15 | -3.17 | -1.01 | -2.08 | -1.82 | -1.61 | -1.24 |
| Other Sources | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | -16.23 | -77.61-262.3% | 47.83+239.2% | 14.10-68.5% | 44.78 | -58.23 | -205.06-572.2% | 43.43 | -26.40 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | 44.32 | 21.14-54.8% | 46.76+145.7% | 19.03+106.6% | 9.21-70.2% | 30.94+27.7% | 24.22+31.3% | 18.45-14.5% | 21.58 |
| Repurchase of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Common Pref Stock | 44.32 | 21.14-54.8% | 46.76+145.7% | 19.03+106.6% | 9.21-70.2% | 30.94+27.7% | 24.22+31.3% | 18.45-14.5% | 21.58 |
| Proceedsfrom Stock Options | 7.81 | 7.69+3.6% | 7.42+18.2% | 6.28+11.5% | 5.63+16.8% | 4.82+19.6% | 4.03+18.9% | 3.39 | -0.59 |
| Issuance or Reduction of Debt, Net | -1.29 | -1.12-102.2% | 51.34 | -0.71 | -0.53 | -0.66-100.3% | 242.21 | -22.50 | 0.00 |
| Change in Long Term Debt | -1.29 | -1.12-102.2% | 51.34 | -0.71 | -0.53 | -0.66-100.3% | 242.21 | -22.50 | 0.00 |
| Issuance of Long Term Debt | 0.00 | 0.00-100.0% | 53.22 | 0.00 | 0.00 | 0.00-100.0% | 287.50 | 0.00 | 0.00 |
| Reduction of Long Term Debt | -1.29 | -1.12 | -1.88 | -0.71 | -0.53 | -0.66 | -45.29 | -22.50 | 0.00 |
| Net Financing Active Other Cash Flow | -9.15 | -8.13 | -6.56 | -3.27 | -2.43-127.1% | 8.98 | -3.89 | -5.60 | 0.00 |
| Other Financing Activities Uses | -9.15 | -8.13 | -6.56 | -3.27 | -2.73 | -3.69 | -3.89 | -5.60 | 0.00 |
| Cash from Financing Activities | 33.87 | 11.89-87.0% | 91.54+508.6% | 15.04+140.6% | 6.25-84.1% | 39.26-85.0% | 262.54 | -9.64-144.7% | 21.58 |
| Exchange Rate Effect | -1.99 | 0.80 | -3.02-325.4% | 1.34 | -1.47 | -1.77 | -0.09 | -0.25-600.0% | 0.05 |
| Net Change in Cash | 63.36 | -79.71-206.2% | 75.04 | -27.28-265.5% | 16.48+316.2% | 3.96-88.5% | 34.41+3.8% | 33.16+135.3% | 14.09 |
| Free Cash Flow | 19.41 | -39.06 | -67.62 | -78.01 | -63.35 | -23.08 | -29.92 | -5.09-159.5% | 8.55 |
| Preferred Dividends (Cash Flow) | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price to Free Cash Flow ratio | 517.58 | - | - | - | - | - | - | - | 232.05 |
| Deferred Taxes & Investment Tax Credit | - | -6.49 | -0.22 | -0.12 | -0.05 | -1.03 | -12.18 | -66.31 | 0.00 |
Balance sheet, quarterly
| Metric | 2026Q39/30/2026 | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q412/31/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 336.70+23.0% | 286.23+4.2% | 276.69-7.4% | 278.76-12.6% | 273.71+4.3% | 274.79+5.0% | 298.70+9.5% | 318.92+8.0% |
| Short Term Receivables | 150.00+52.0% | 138.90+67.4% | 119.69+67.3% | 108.61+78.8% | 98.68+74.9% | 82.98+62.0% | 71.53+53.7% | 60.74+52.4% |
| Inventories | 61.03-4.4% | 59.31-8.2% | 62.38+4.9% | 63.56+10.2% | 63.86+6.6% | 64.62+14.4% | 59.46+18.5% | 57.68+37.4% |
| Other Current Assets | 31.91+72.4% | 31.35+129.3% | 26.99+81.6% | 24.05+93.0% | 18.510.0% | 13.67-5.2% | 14.86-21.9% | 12.46-31.5% |
| Total Current Assets | 579.65+27.5% | 515.78+18.3% | 485.75+9.3% | 474.98+5.6% | 454.77+14.5% | 436.06+13.6% | 444.54+14.4% | 449.79+13.7% |
| Net Property, Plant & Equipment | 180.46-1.1% | 181.58-1.5% | 182.26+7.1% | 184.18+8.4% | 182.49+8.5% | 184.41+8.7% | 170.20-1.1% | 169.94-2.6% |
| Total Investments and Advances | 27.14+20.2% | 26.54+26.1% | 23.66+19.1% | 23.38+20.1% | 22.57+15.4% | 21.04+14.3% | 19.87+7.5% | 19.47+232.3% |
| Intangible Assets | 187.97-43.2% | 193.86-42.5% | 199.74-38.4% | 208.63-36.7% | 330.85-1.4% | 337.20-1.3% | 324.00-6.9% | 329.58-5.6% |
| Deferred Tax Assets | - | - | - | 36.89-39.9% | - | - | - | 61.39-7.7% |
| Other Assets | 4.31-50.5% | 2.76-66.5% | 1.92-74.6% | 2.32-61.1% | 8.70+47.7% | 8.24+36.2% | 7.56+24.5% | 5.97-61.4% |
| Total Assets | 979.53-2.0% | 920.52-6.7% | 893.33-7.5% | 930.37-10.2% | 999.38+7.9% | 986.96+7.3% | 966.18+3.5% | 1,036.15+2.9% |
| Short Term Debt Incl. Current Port. of LT Debt | 0.00 | 0.00 | 0.00 | 2.67+8.1% | 0.00 | 0.00 | 0.00 | 2.47+88.5% |
| Accounts Payable | 24.41+22.8% | 19.14+39.9% | 19.15+21.0% | 24.62+88.9% | 19.88+79.1% | 13.68+18.3% | 15.82+24.1% | 13.03-3.1% |
| Other Current Liabilities | 102.32+51.3% | 83.19+27.1% | 70.26+33.3% | 73.98+24.1% | 67.63+11.6% | 65.45+11.8% | 52.70-11.4% | 59.62+0.6% |
| Total Current Liabilities | 126.73+44.8% | 102.33+29.3% | 89.42+30.5% | 101.28+34.8% | 87.52+22.1% | 79.14+12.9% | 68.53-5.1% | 75.12+1.5% |
| Long Term Debt | 101.98-2.2% | 102.84-2.1% | 103.06-2.3% | 103.88+0.5% | 104.31-33.6% | 105.02-32.9% | 105.48-72.5% | 103.40-73.1% |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Liabilities | 0.44-93.6% | 0.44-93.6% | 0.44-93.6% | 37.33-45.4% | 6.92-3.1% | 6.91-3.2% | 6.92-3.1% | 68.32-7.3% |
| Other Liabilities | 33.10+6.5% | 32.43+5.4% | 29.49+38.5% | 31.74+41.9% | 31.08+40.8% | 30.78+48.8% | 21.29+8.0% | 22.37+62.7% |
| Total Liabilities | 262.25+14.1% | 238.03+7.3% | 222.40+10.0% | 274.22+1.9% | 229.84-10.9% | 221.85-12.8% | 202.22-58.1% | 269.22-50.6% |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 717.27-6.8% | 682.49-10.8% | 670.93-12.2% | 656.15-14.4% | 769.54+15.1% | 765.11+15.0% | 763.96+69.5% | 766.93+66.1% |
| Total Shareholders Equity | 717.27-6.8% | 682.49-10.8% | 670.93-12.2% | 656.15-14.4% | 769.54+15.1% | 765.11+15.0% | 763.96+69.5% | 766.93+66.1% |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | 717.27-6.8% | 682.49-10.8% | 670.93-12.2% | 656.15-14.4% | 769.54+15.1% | 765.11+15.0% | 763.96+69.5% | 766.93+66.1% |
| Total Liabilities & Stockholders Equity | 979.53-2.0% | 920.52-6.7% | 893.33-7.5% | 930.37-10.2% | 999.38+7.9% | 986.96+7.3% | 966.18+3.5% | 1,036.15+2.9% |
| Book Value Per Share per share | 12.12-9.6% | 11.60-13.2% | 11.50-14.6% | 11.41-16.0% | 13.41+10.6% | 13.36+10.1% | 13.46+48.9% | 13.59+44.6% |
| Tangible Book Value Per Share per share | 8.95+17.1% | 8.30+11.1% | 8.07+4.1% | 7.78+0.4% | 7.64+26.5% | 7.47+26.6% | 7.75+276.2% | 7.75+238.4% |
| Full-Time Employees people | - | - | - | 1,094+9.9% | - | - | - | 995+9.7% |
| Price to Book Ratio ratio | 20.30 | 12.16 | 9.44 | 8.42 | 6.10 | 7.67 | 7.24 | 12.36 |
| Return on Assets % | -17.16 | -19.72 | -20.36 | -19.09 | -9.10 | -9.73 | -13.02 | -14.33 |
| Return on Equity % | -22.84 | -25.98 | -26.39 | -26.38 | -12.19 | -12.98 | -20.36 | -23.83 |
| Return on Invested Capital % | 0.25 | -2.34 | -2.56 | -17.59 | -1.86 | -2.26 | -2.09 | -3.86 |
| Quick Ratio ratio | 4.09 | 4.46 | 4.73 | 4.06 | 4.47 | 4.69 | 5.62 | 5.22 |
| Current Ratio ratio | 4.57 | 5.04 | 5.43 | 4.69 | 5.20 | 5.51 | 6.49 | 5.99 |
Cash flow, quarterly
| Metric | 2026Q39/30/2026 | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q412/31/2024 |
|---|---|---|---|---|---|---|---|---|
| Net Income | 2.02 | -18.38 | -19.78 | -133.66 | -16.23 | -19.66 | -18.15 | -33.58 |
| Depreciation | 10.03-1.6% | 10.14+5.4% | 12.88+38.5% | 13.23+1.7% | 10.19+48.3% | 9.62-4.4% | 9.30-6.8% | 13.01+35.2% |
| Other Funds (Non Cash) | 33.70+190.5% | 34.25+42.3% | 18.21+34.7% | 135.88+600.8% | 11.60-26.1% | 24.07-20.7% | 13.52-30.3% | 19.39+68.0% |
| Funds from Operations | 45.75+721.4% | 26.02+85.5% | 11.31+142.2% | 8.97 | 5.57+380.2% | 14.03 | 4.67 | -1.39 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | -7.18 | -11.19 | -23.83 | -2.13-212.1% | -15.66 | -7.05 | -23.19 | 1.90-62.4% |
| Cash from Operating Activities | 38.57 | 14.82+112.3% | -12.53 | 6.84+1241.2% | -10.09 | 6.98 | -18.52 | 0.51 |
| Capital Expenditures | -2.08 | -2.74 | -3.96 | -19.52 | -1.64 | -1.18 | -1.94 | -1.73 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -12.44 | 0.00 | 0.00 |
| Sale of Fixed Assets and Businesses | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 0.00 | 0.00 |
| Purchase or Sale of Investments | -2.86 | 0.56-95.1% | 15.22 | -12.18-190.6% | -0.82-102.5% | 11.51-69.7% | -33.87 | 13.44 |
| Purchase of Investments | -52.55 | -35.49 | -31.35 | -40.16 | -75.37 | -42.02 | -74.74 | -66.86 |
| Sale Or Maturity of Investments | 49.69-33.3% | 36.05-32.7% | 46.58+13.9% | 27.98-65.2% | 74.54+14.4% | 53.53-33.0% | 40.88+86.8% | 80.31+24.8% |
| Other Uses | -0.60 | -3.13 | -0.76 | 15.81+19662.5% | -1.53 | -18.68 | -1.15 | 0.08 |
| Other Sources | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | -5.54 | -5.31 | 10.50 | -15.89-234.8% | -3.99-113.1% | -20.78-159.6% | -36.95 | 11.79 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Dividends (Cash Flow) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | 15.59+151.0% | 4.10-17.5% | 21.71+208.4% | 2.92-70.3% | 6.21-39.4% | 4.97-54.6% | 7.04-55.3% | 9.84+60.8% |
| Repurchase of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Common Pref Stock | 15.59+151.0% | 4.10-17.5% | 21.71+208.4% | 2.92-70.3% | 6.21-39.4% | 4.97-54.6% | 7.04-55.3% | 9.84+60.8% |
| Proceedsfrom Stock Options | 5.43+15.0% | 0.00 | 2.38-19.6% | 0.00 | 4.72-0.2% | 0.00 | 2.96+10.0% | 0.00 |
| Issuance or Reduction of Debt, Net | -0.35 | -0.34 | -0.30 | -0.30-100.6% | -0.29 | -0.28 | -0.25 | 52.01 |
| Change in Long Term Debt | -0.35 | -0.34 | -0.30 | -0.30-100.6% | -0.29 | -0.28 | -0.25 | 52.01 |
| Issuance of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 0.00 | 0.00 | 0.00 | 53.22 |
| Reduction of Long Term Debt | -0.35 | -0.34 | -0.30 | -0.30 | -0.29 | -0.28 | -0.25 | -1.22 |
| Net Financing Active Other Cash Flow | -0.55 | -2.77 | -5.64 | -0.19 | -0.65 | -2.45 | -4.84 | -1.73-226.3% |
| Other Financing Activities Uses | -0.55 | -2.77 | -5.64 | -0.19 | -0.65 | -2.45 | -4.84 | -1.73-226.3% |
| Cash from Financing Activities | 14.69+179.3% | 0.99-56.0% | 15.77+708.7% | 2.43-96.0% | 5.26-45.6% | 2.25-73.8% | 1.95-85.2% | 60.11+723.4% |
| Exchange Rate Effect | 0.13-97.9% | -0.99 | -0.31 | -0.81 | 6.25+340.1% | -2.78 | -1.85 | -2.92-456.1% |
| Net Change in Cash | 47.84 | 9.52 | 13.44 | -7.43-110.7% | -2.57-108.0% | -14.34-158.6% | -55.37 | 69.48 |
| Free Cash Flow | 36.49 | 12.09+108.4% | -16.48 | -12.68 | -11.72 | 5.80 | -20.46 | -1.23 |
| Price to Free Cash Flow ratio | 517.58 | - | - | - | - | - | - | - |
Revenue breakdown
USD millions, so a column adds up to the income statement. Share is of the latest year in that split. The change is versus the older year shown, not TTM.
| Name | 2024 | 2025 | vs 2024 | 2025 share |
|---|---|---|---|---|
| Corneal Health | 80.21 | 86.37 | +7.7% | 17.0% |
| Glaucoma | 303.28 | 421.07 | +38.8% | 83.0% |
| Total | 383.48 | 507.44 | +32.3% | 100.0% |
| Name | 2024 | 2025 | vs 2024 | 2025 share |
|---|---|---|---|---|
| Non-US | 113.39 | 132.40 | +16.8% | 26.1% |
| United States | 270.09 | 375.04 | +38.9% | 73.9% |
| Total | 383.48 | 507.44 | +32.3% | 100.0% |
Short interest
shares short against float, oldest to newest| Settlement | Of float | Shares short | Float | Avg volume |
|---|---|---|---|---|
| 2026-10-30 | 7.89% | 4.5M | 56.9M | 950.48K |
| 2026-10-15 | 7.67% | 4.3M | 56.6M | 851.68K |
| 2026-09-30 | 6.80% | 3.9M | 56.6M | 796.92K |
| 2026-09-15 | 7.36% | 4.2M | 56.6M | 802.96K |
| 2026-08-31 | 6.75% | 3.8M | 56.6M | 881.86K |
| 2026-08-14 | 6.98% | 4.0M | 56.6M | 1.03M |
| 2026-07-31 | 6.40% | 3.6M | 56.6M | 1.03M |
| 2026-07-15 | 8.34% | 4.7M | 56.4M | 994.97K |
| 2026-06-30 | 7.89% | 4.4M | 56.4M | 975.52K |
| 2026-06-15 | 7.41% | 4.2M | 56.4M | 934.08K |
| 2026-05-29 | 5.53% | 3.1M | 56.4M | 850.87K |
| 2026-05-15 | 5.86% | 3.3M | 56.4M | 763.09K |
| 2026-04-30 | 5.18% | 2.9M | 56.1M | 745.10K |
| 2026-04-15 | 5.83% | 3.2M | 55.5M | 777.64K |
| 2026-03-31 | 5.59% | 3.1M | 55.5M | 798.32K |
| 2026-03-13 | 4.82% | 2.7M | 55.5M | 780.95K |
| 2026-02-27 | 5.18% | 2.9M | 55.5M | 769.98K |
| 2026-02-13 | 4.87% | 2.7M | 55.5M | 801.54K |
| 2026-01-30 | 4.51% | 2.5M | 55.0M | 904.16K |
| 2026-01-15 | 4.05% | 2.2M | 55.0M | 1.10M |
Option chain
expiry 2026-11-20| Type | Strike | Bid | Ask | Last | IV | Open int | Volume | Delta | Theta | Vega |
|---|---|---|---|---|---|---|---|---|---|---|
| call | 100 | 144.2 | 148 | 0.00 | 364.5% | 0.00 | 0.00 | 0.997 | -0.068 | 0.004 |
| call | 105 | 139.2 | 143.2 | 0.00 | 346.6% | 0.00 | 0.00 | 0.996 | -0.068 | 0.004 |
| call | 110 | 134.2 | 138.2 | 0.00 | 329.4% | 0.00 | 0.00 | 0.996 | -0.068 | 0.004 |
| call | 115 | 129.2 | 133.2 | 0.00 | 313.1% | 0.00 | 0.00 | 0.996 | -0.069 | 0.004 |
| call | 120 | 124.2 | 128 | 0.00 | 297.5% | 0.00 | 0.00 | 0.996 | -0.069 | 0.004 |
| call | 125 | 119.2 | 123 | 50.00 | 289.9% | 1.00 | 0.00 | 0.996 | -0.069 | 0.005 |
| call | 130 | 114.2 | 118 | 0.00 | 268.1% | 0.00 | 0.00 | 0.995 | -0.069 | 0.005 |
| call | 135 | 109.2 | 113 | 0.00 | 254.3% | 0.00 | 0.00 | 0.995 | -0.069 | 0.005 |
| call | 140 | 104.3 | 108 | 26.64 | 247.4% | 1.00 | 0.00 | 0.995 | -0.069 | 0.005 |
| call | 145 | 99.30 | 102.6 | 80.20 | 228.0% | 1.00 | 0.00 | 0.960 | -0.465 | 0.031 |
| call | 150 | 94.60 | 97.60 | 97.65 | 215.4% | 2.00 | 2.00 | 0.958 | -0.461 | 0.032 |
| call | 155 | 89.60 | 92.60 | 72.90 | 203.3% | 5.00 | 0.00 | 0.956 | -0.455 | 0.034 |
| call | 160 | 84.30 | 88.00 | 67.90 | 197.0% | 8.00 | 0.00 | 0.953 | -0.450 | 0.035 |
| call | 165 | 79.60 | 83.20 | 20.96 | 185.3% | 10.00 | 0.00 | 0.950 | -0.444 | 0.037 |
| call | 170 | 74.30 | 78.30 | 67.90 | 173.9% | 42.00 | 0.00 | 0.947 | -0.438 | 0.039 |
| call | 175 | 69.30 | 73.00 | 59.50 | 160.3% | 44.00 | 0.00 | 0.944 | -0.431 | 0.041 |
| call | 180 | 64.40 | 68.00 | 60.78 | 149.5% | 276 | 0.00 | 0.940 | -0.424 | 0.043 |
| call | 185 | 59.30 | 63.30 | 54.20 | 138.9% | 31.00 | 0.00 | 0.936 | -0.416 | 0.045 |
| call | 190 | 54.30 | 58.40 | 12.10 | 128.6% | 27.00 | 0.00 | 0.931 | -0.407 | 0.048 |
| call | 195 | 49.40 | 53.40 | 43.20 | 122.1% | 25.00 | 0.00 | 0.886 | -0.664 | 0.070 |
| call | 200 | 44.40 | 48.20 | 25.80 | 110.1% | 306 | 0.00 | 0.877 | -0.645 | 0.073 |
| call | 210 | 34.70 | 38.50 | 33.05 | 96.0% | 25.00 | 0.00 | 0.856 | -0.601 | 0.082 |
| call | 220 | 25.90 | 28.40 | 18.70 | 75.3% | 38.00 | 0.00 | 0.825 | -0.546 | 0.093 |
| call | 230 | 16.90 | 19.80 | 19.80 | 67.9% | 19.00 | 1.00 | 0.759 | -0.536 | 0.112 |
| call | 240 | 10.70 | 12.50 | 9.38 | 63.7% | 19.00 | 0.00 | 0.627 | -0.583 | 0.137 |
| call | 250 | 5.60 | 7.60 | 5.60 | 64.1% | 233 | 3.00 | 0.456 | -0.592 | 0.143 |
| call | 260 | 2.10 | 4.40 | 3.55 | 65.8% | 170 | 0.00 | 0.306 | -0.543 | 0.127 |
| call | 270 | 0.00 | 4.90 | 1.50 | 86.6% | 83.00 | 0.00 | 0.255 | -0.644 | 0.116 |
| call | 280 | 0.00 | 4.90 | 2.00 | 104.2% | 12.00 | 0.00 | 0.223 | -0.722 | 0.108 |
| call | 290 | 0.00 | 4.90 | 0.00 | 113.1% | 0.00 | 0.00 | 0.184 | -0.697 | 0.096 |
| call | 300 | 0.00 | 4.90 | 0.00 | 105.5% | 1.00 | 0.00 | 0.115 | -0.474 | 0.070 |
| call | 310 | 0.00 | 4.90 | 0.01 | 117.4% | 2.00 | 0.00 | 0.106 | -0.497 | 0.066 |
| call | 320 | 0.00 | 4.90 | 0.00 | 128.8% | 0.00 | 0.00 | 0.098 | -0.517 | 0.063 |
| call | 330 | 0.00 | 4.90 | 0.00 | 139.6% | 0.00 | 0.00 | 0.092 | -0.535 | 0.060 |
| call | 340 | 0.00 | 4.90 | 0.00 | 150.1% | 0.00 | 0.00 | 0.087 | -0.551 | 0.057 |
| call | 350 | 0.00 | 4.90 | 0.00 | 159.9% | 0.00 | 0.00 | 0.083 | -0.566 | 0.055 |
| call | 360 | 0.00 | 4.90 | 0.00 | 169.3% | 0.00 | 0.00 | 0.080 | -0.579 | 0.053 |
| put | 100 | 0.00 | 5.00 | 0.01 | 243.0% | 4.00 | 0.00 | -0.003 | -0.057 | 0.004 |
| put | 105 | 0.00 | 5.00 | 1.00 | 230.6% | 7.00 | 0.00 | -0.004 | -0.056 | 0.004 |
| put | 110 | 0.00 | 5.00 | 1.10 | 218.8% | 3.00 | 0.00 | -0.004 | -0.056 | 0.004 |
| put | 115 | 0.00 | 5.00 | 2.35 | 207.5% | 7.00 | 0.00 | -0.004 | -0.056 | 0.004 |
| put | 120 | 0.00 | 5.00 | 0.01 | 196.7% | 4.00 | 0.00 | -0.004 | -0.055 | 0.004 |
| put | 125 | 0.00 | 4.90 | 0.08 | 186.3% | 12.00 | 0.00 | -0.004 | -0.055 | 0.005 |
| put | 130 | 0.00 | 3.40 | 1.07 | 176.5% | 13.00 | 0.00 | -0.005 | -0.055 | 0.005 |
| put | 135 | 0.00 | 3.40 | 2.10 | 166.8% | 30.00 | 0.00 | -0.005 | -0.054 | 0.005 |
| put | 140 | 0.00 | 0.10 | 0.05 | 149.6% | 101 | 0.00 | -0.005 | -0.048 | 0.006 |
| put | 145 | 0.00 | 3.40 | 0.14 | 228.2% | 36.00 | 0.00 | -0.040 | -0.449 | 0.031 |
| put | 150 | 0.00 | 2.80 | 1.09 | 215.7% | 2,041 | 0.00 | -0.042 | -0.444 | 0.032 |
| put | 155 | 0.00 | 3.40 | 6.10 | 203.7% | 127 | 0.00 | -0.044 | -0.438 | 0.034 |
| put | 160 | 0.00 | 4.90 | 0.31 | 191.9% | 118 | 0.00 | -0.047 | -0.432 | 0.035 |
| put | 165 | 0.00 | 4.90 | 0.05 | 180.7% | 2,111 | 0.00 | -0.050 | -0.426 | 0.037 |
| put | 170 | 0.00 | 4.90 | 9.75 | 169.6% | 855 | 0.00 | -0.053 | -0.419 | 0.039 |
| put | 175 | 0.00 | 4.90 | 0.05 | 158.5% | 295 | 0.00 | -0.056 | -0.411 | 0.041 |
| put | 180 | 0.00 | 4.90 | 0.80 | 148.1% | 177 | 0.00 | -0.060 | -0.404 | 0.043 |
| put | 185 | 0.00 | 4.90 | 1.20 | 137.4% | 59.00 | 0.00 | -0.064 | -0.395 | 0.045 |
| put | 190 | 0.00 | 1.50 | 0.65 | 120.4% | 48.00 | 0.00 | -0.057 | -0.316 | 0.042 |
| put | 195 | 0.00 | 4.80 | 0.95 | 145.4% | 11.00 | 0.00 | -0.114 | -0.643 | 0.070 |
| put | 200 | 0.00 | 4.90 | 1.00 | 133.9% | 117 | 0.00 | -0.123 | -0.623 | 0.073 |
| put | 210 | 0.00 | 4.20 | 2.30 | 111.3% | 90.00 | 0.00 | -0.144 | -0.578 | 0.082 |
| put | 220 | 0.05 | 3.20 | 1.85 | 88.8% | 152 | 0.00 | -0.175 | -0.521 | 0.093 |
| put | 230 | 1.20 | 4.00 | 2.75 | 72.8% | 2,406 | 1.00 | -0.242 | -0.511 | 0.113 |
| put | 240 | 4.10 | 6.50 | 6.30 | 65.9% | 40.00 | 0.00 | -0.373 | -0.554 | 0.136 |
| put | 250 | 8.80 | 11.00 | 9.30 | 62.7% | 104 | 5.00 | -0.544 | -0.564 | 0.143 |
| put | 260 | 15.30 | 18.20 | 14.00 | 67.4% | 14.00 | 0.00 | -0.694 | -0.514 | 0.127 |
| put | 270 | 23.30 | 27.00 | 39.40 | 75.8% | 26.00 | 0.00 | -0.748 | -0.606 | 0.115 |
| put | 280 | 32.70 | 36.20 | 0.00 | 91.8% | 0.00 | 0.00 | -0.779 | -0.680 | 0.107 |
| put | 290 | 42.60 | 45.90 | 60.50 | 103.7% | 0.00 | 0.00 | -0.801 | -0.739 | 0.101 |
| put | 300 | 52.20 | 55.90 | 68.50 | 117.6% | 0.00 | 0.00 | -0.885 | -0.440 | 0.070 |
| put | 310 | 62.50 | 65.90 | 0.00 | 130.6% | 0.00 | 0.00 | -0.894 | -0.462 | 0.066 |
| put | 320 | 72.00 | 75.90 | 0.00 | 142.8% | 0.00 | 0.00 | -0.902 | -0.481 | 0.063 |
| put | 330 | 82.50 | 85.90 | 0.00 | 152.9% | 0.00 | 0.00 | -0.908 | -0.498 | 0.060 |
| put | 340 | 92.50 | 95.90 | 0.00 | 163.8% | 0.00 | 0.00 | -0.913 | -0.513 | 0.057 |
| put | 350 | 102.5 | 105.9 | 0.00 | 174.3% | 0.00 | 0.00 | -0.917 | -0.526 | 0.055 |
| put | 360 | 112.5 | 115.9 | 0.00 | 184.2% | 0.00 | 0.00 | -0.920 | -0.539 | 0.053 |
Latest SEC filings
30| Filed | Form | Description | Period | Link |
|---|---|---|---|---|
| 2026-11-12 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-11-06 | 8-K | Current report | 2026-11-06 | SEC |
| 2026-11-05 | 4 | Statement of changes in beneficial ownership of securities | 2026-11-04 | SEC |
| 2026-11-04 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-11-03 | 4 | Statement of changes in beneficial ownership of securities | 2026-10-30 | SEC |
| 2026-11-03 | 4 | Statement of changes in beneficial ownership of securities | 2026-10-30 | SEC |
| 2026-11-03 | 4 | Statement of changes in beneficial ownership of securities | 2024-04-09 | SEC |
| 2026-10-30 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-10-28 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-09-30 | SEC |
| 2026-10-28 | 8-K | Current report | 2026-10-28 | SEC |
| 2026-10-07 | 4 | Statement of changes in beneficial ownership of securities | 2026-10-05 | SEC |
| 2026-10-05 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-09-28 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-25 | SEC |
| 2026-09-25 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-09-18 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-16 | SEC |
| 2026-09-16 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-09-01 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-28 | SEC |
| 2026-08-28 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-08-20 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-19 | SEC |
| 2026-08-19 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-08-13 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-11 | SEC |
| 2026-08-11 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-08-11 | 4 | Statement of changes in beneficial ownership of securities | 2026-08-07 | SEC |
| 2026-08-07 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-08-03 | 4 | Statement of changes in beneficial ownership of securities | 2026-07-31 | SEC |
| 2026-08-03 | 8-K | Current report | 2026-08-03 | SEC |
| 2026-07-31 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-07-29 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-06-30 | SEC |
| 2026-07-29 | 8-K | Current report | 2026-07-29 | SEC |
| 2026-07-21 | 4 | Statement of changes in beneficial ownership of securities | 2026-07-16 | SEC |
Insider activity by month
| Month | Bought | Buys | Sold | Sells |
|---|---|---|---|---|
| 2026-11 | 0 | 0 | 632.50K | 1 |
| 2026-10 | 0 | 0 | 10.87M | 2 |
| 2026-09 | 0 | 0 | 492.36K | 2 |
| 2026-08 | 0 | 0 | 17.35M | 4 |
| 2026-07 | 0 | 0 | 4.84M | 5 |
| 2026-06 | 0 | 0 | 200.86K | 1 |
| 2026-05 | 0 | 0 | 4.43M | 4 |
| 2026-04 | 0 | 0 | 1.65M | 2 |
| 2026-03 | 0 | 0 | 590.44K | 4 |
| 2026-02 | 0 | 0 | 1.76M | 1 |
| 2026-01 | 0 | 0 | 35.44M | 5 |
| 2025-12 | 0 | 0 | 536.35K | 1 |
| 2025-11 | 0 | 0 | 1.77M | 2 |
Institutional holders
| Manager | % owned |
|---|---|
| BlackRock, Inc. | 16.24% |
| Jupiter Topco LLC | 8.28% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 5.66% |
| PRIMECAP MANAGEMENT CO/CA/ | 5.22% |
| FMR LLC | 4.86% |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.34% |
| STATE STREET CORP | 3.92% |
| MILLENNIUM MANAGEMENT LLC | 2.69% |
| Holocene Advisors, LP | 2.58% |
| GEODE CAPITAL MANAGEMENT, LLC | 2.46% |
Funds
| Fund | % owned |
|---|---|
| iShares Core S&P Small-Cap ETF | 6.02% |
| VANGUARD TOTAL STOCK MARKET INDEX FUND | 3.02% |
| iShares Russell 2000 ETF | 2.52% |
| VANGUARD CAPITAL OPPORTUNITY FUND | 2.52% |
| VANGUARD SMALL-CAP INDEX FUND | 2.18% |
| Janus Henderson Triton Fund | 1.80% |
| PRIMECAP Odyssey Aggressive Growth Fund | 1.71% |
| SMALLCAP World Fund Inc | 1.68% |
| VANGUARD SMALL-CAP GROWTH INDEX FUND | 1.26% |
| Janus Henderson Enterprise Fund | 1.21% |
OakChart. GKOS. Cached 15 minutes. Terms